Larkspur Health Acquisition Corp.
closedU=S+W/2W=S@11.50
ZVSA
Capital Structure & Economics
Trust Size$75,000,000
Unit Price$10.00
Warrant Coverage1/2
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
50% Warrant Inclusion| Public Trust Allocation | $75,000,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $10.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedMay 13, 2021
SearchingTarget Pending
Maturation Wall
May 23, 2023
Announced Target / M&A
- Target CompanyZyVersa Therapeutics, Inc.
- Sectorbiopharmaceutical
- Announced Deal Size$85,000,000
Board & Officers
- Stephen C. GloverCEO
- Daniel J. O’ConnorOfficer
- David S. BrionesOfficer
- M2B Funding CorporationOfficer
- Apollo Management Group, IncOfficer
- Alpha Capital Anstalt(2)Officer
- Range Ventures, LLCOfficer
- Nicholas KovacevichOfficer
- Officer
- Thomas PolettiOfficer
- L1 Capital Global Opportunities Master Fund, Ltd.Officer
- S.H.N. Financial Investments Ltd.Officer
- Mitchell SchiffOfficer
- Lakespur Holdings LLCOfficer
- Jeffry BernsteinOfficer
Advanced Structuring Terms
| Target Sectors | biopharmaceutical |
Syndicate & Advisors
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.